These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 5835631)

  • 1. [Quantitative determination of the fibrinolytic tissue activator in normal and pathological skin].
    Haustein UF
    Arch Klin Exp Dermatol; 1968; 232(3):245-59. PubMed ID: 5678271
    [No Abstract]   [Full Text] [Related]  

  • 2. [Problems associated with transfusion of post mortem blood].
    Volk P; Gostomzyk JG; Schäfer B; Reck R
    Z Rechtsmed; 1970; 67(1):1-18. PubMed ID: 4924651
    [No Abstract]   [Full Text] [Related]  

  • 3. EPSILON-AMINOCAPROIC ACID AND OTHER INHIBITORS OF FIBRINOLYSIS.
    MCNICOL GP; DOUGLAS AS
    Br Med Bull; 1964 Sep; 20():233-9. PubMed ID: 14209764
    [No Abstract]   [Full Text] [Related]  

  • 4. The fibrinolytic system--basic considerations.
    Castellino FJ; Violand BN
    Prog Cardiovasc Dis; 1979; 21(4):241-54. PubMed ID: 368879
    [No Abstract]   [Full Text] [Related]  

  • 5. Action of 3,4,5-trimethoxybenzoyl-epsilon-amino caproic acid on platelet aggregation and on the activation of plasminogen by streptokinase.
    Rognoni F; Garzia A; Ariano M
    Atherosclerosis; 1971; 14(3):375-8. PubMed ID: 5135230
    [No Abstract]   [Full Text] [Related]  

  • 6. [EPSILON-AMINOCAPROIC ACID AND FIBRINOLYSIS].
    VAIREL E; LANDE M; LEGER L
    Presse Med (1893); 1964 Mar; 72():945-6. PubMed ID: 14119753
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasminogen-plasmin system. 3. Kinetics of plasminogen activation and inhibition of plasminogen-plasmin system by some synthetic inhibitors.
    Iwamoto M; Abiko Y; Shimizu M
    J Biochem; 1968 Dec; 64(6):759-67. PubMed ID: 4238017
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of EACA, PAMBA, AMCA and AMBOCA on fibrinolysis induced by streptokinase, urokinase and tissue activator.
    Westlund LE; Lundén R; Wallén P
    Haemostasis; 1982; 11(4):235-41. PubMed ID: 6982199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinolysis in the central nervous system.
    Porter JM; Acinapura AJ; Kapp JP; Silver D
    Neurology; 1969 Jan; 19(1):47-52. PubMed ID: 5813126
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of intravenously administered streptokinase on fibrinolysis and blood coagulation].
    DEUTSCH E; FISCHER M
    Thromb Diath Haemorrh; 1960 Jun; 4():482-506. PubMed ID: 13816260
    [No Abstract]   [Full Text] [Related]  

  • 11. Heat denaturation of plasminogen in the fibrin plate method.
    LASSEN M
    Acta Physiol Scand; 1953 Feb; 27(4):371-6. PubMed ID: 13065142
    [No Abstract]   [Full Text] [Related]  

  • 12. Fibrinolytic activity of human blood after death.
    MULLERTZ S
    Acta Physiol Scand; 1952; 27(2-3):265-71. PubMed ID: 13050486
    [No Abstract]   [Full Text] [Related]  

  • 13. The fibrin plate method for estimating fibrinolytic activity.
    ASTRUP T; MULLERTZ S
    Arch Biochem Biophys; 1952 Oct; 40(2):346-51. PubMed ID: 12997222
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the problem of postmortem fibrinolysis. Activation and inhibition of postmortem fibrinolysis with streptokinase and epsilon-aminocaprioic acid].
    Harms D
    Blut; 1965 Sep; 11(6):345-51. PubMed ID: 5835631
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.